Irbesartan vs Rituximab
Irbesartan vs Rituximab: Overview
This comparison examines the pharmacological differences between Irbesartan and Rituximab.
Mechanism of Action
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Irbesartan — 11-15 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Irbesartan — C25H28N6O.
Molecular Weight: Irbesartan — 428.5320 g/mol.
Type: Irbesartan — Small molecule; Rituximab — Antibody.